MicroRNA expression altered by diet: Can food be medicinal?

Ageing Research Reviews

Volumn 17, Issue , 2014, Pages 16-24

  Palmer, Joshua D ^a   Soule, Benjamin P ^a   Simone, Brittany A ^a   Zaorsky, Nicholas G ^b   Jin, Lianjin ^a   Simone, Nicole L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Aging; Cancer; Diet; MicroRNA; MiR; Nutrition

Indexed keywords

FAT; FOLIC ACID; GLUCOSE; MICRORNA; MICRORNA 200; MICRORNA 203; MICRORNA 221; POLYUNSATURATED FATTY ACID; SMALL UNTRANSLATED RNA; TRACE ELEMENT; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

AGING; CALORIC RESTRICTION; CHRONIC DISEASE; DIET; DISEASE COURSE; GENE EXPRESSION; HIGH FIBER DIET; HUMAN; LIPID DIET; NUTRITION; OBESITY; PROTEIN EXPRESSION; REVIEW; WEIGHT REDUCTION; FOOD; MEDICINAL PLANT; METABOLISM;

BIOLOGICAL MARKERS; DIET; FOOD; HUMANS; MICRORNAS; PLANTS, MEDICINAL;

EID: 84906349862     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2014.04.005     Document Type: Review

References (71)

1. Ali A.S., Ali S., Ahmad A., Bao B., Philip P.A., Sarkar F.H. Expression of microRNAs: potential molecular link between obesity, diabetes and cancer. Obes. Rev. 2011, 12(12):1050-1062.
2. Alisi A., Da Sacco L., Bruscalupi G., Piemonte F., Panera N., De Vito R., Leoni S., Bottazzo G.F., Masotti A., Nobili V. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced non-alcoholic fatty liver disease. Lab. Invest. 2011, 91(2):283-293.
3. Anson R.M., Guo Z., de Cabo R., Iyun T., Rios M., Hagepanos A., Ingram D.K., Lane M.A., Mattson M.P. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci USA 2003, 100(10):6216-6220.
4. Bao B., Wang Z., Li Y., Kong D., Ali S., Banerjee S., Ahmad A., Sarkar F.H. The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochim. Biophys. Acta 2011, 1815(2):135-146.
5. Bates D.J., Liang R., Li N., Wang E. The impact of non-coding RNA on the biochemical and molecular mechanisms of aging. Biochim. Biophys. Acta 2009, 1790(10):970-979.
6. Chakraborty C., George Priya Doss C., Bandyopadhyay S. miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the 'minute and miracle' molecule moving as a monitor in the 'genomic galaxy'. Curr. Drug Targets 2013, 14(10):1110-1117.
7. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65(14):6029-6033.
8. Chartoumpekis D.V., Zaravinos A., Ziros P.G., Iskrenova R.P., Psyrogiannis A.I., Kyriazopoulou V.E., Habeos I.G. Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One 2012, 7(4):e34872.
9. Cheng Y., Zhang C. MicroRNA-21 in cardiovascular disease. J. Cardiovasc. Transl. Res. 2010, 3(3):251-255.
10. Cox M.B., Cairns M.J., Gandhi K.S., Carroll A.P., Moscovis S., Stewart G.J., Broadley S., Scott R.J., Booth D.R., Lechner-Scott J., Zgene A.N., Multiple Sclerosis Genetics Consortium MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 2010, 5(8):e12132.
11. Dey N., Das F., Mariappan M.M., Mandal C.C., Ghosh-Choudhury N., Kasinath B.S., Choudhury G.G. MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J. Biol. Chem. 2011, 286(29):25586-25603.
12. Dhar S., Hicks C., Levenson A.S. Resveratrol and prostate cancer: promising role for microRNAs. Mol. Nutr. Food Res. 2011, 55(8):1219-1229.
13. Ferguson L.R. Role of dietary mutagens in cancer and atherosclerosis. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12(4):343-349.
14. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., Weber M., Hamm C.W., Roxe T., Muller-Ardogan M., Bonauer A., Zeiher A.M., Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 2010, 107(5):677-684.
15. Frost R.J., Olson E.N. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(52):21075-21080.
16. Furuta M., Kozaki K.I., Tanaka S., Arii S., Imoto I., Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010, 31(5):766-776.
17. Garcia-Segura L., Perez-Andrade M., Miranda-Rios J. The emerging role of MicroRNAs in the regulation of gene expression by nutrients. J. Nutrigenet. Nutrigenomics 2013, 6(1):16-31.
18. Garofalo M., Quintavalle C., Romano G., Croce C.M., Condorelli G. miR221/222 in cancer: their role in tumor progression and response to therapy. Curr. Mol. Med. 2012, 12:27-33.
19. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10(5):593-601.
20. Grillari J., Hackl M., Grillari-Voglauer R. miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology 2010, 11(4):501-506.
21. Hackl M., Brunner S., Fortschegger K., Schreiner C., Micutkova L., Muck C., Laschober G.T., Lepperdinger G., Sampson N., Berger P., Herndler-Branstetter D., Wieser M., Kuhnel H., Strasser A., Rinnerthaler M., Breitenbach M., Mildner M., Eckhart L., Tschachler E., Trost A., Bauer J.W., Papak C., Trajanoski Z., Scheideler M., Grillari-Voglauer R., Grubeck-Loebenstein B., Jansen-Durr P., Grillari J. miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell 2010, 9(2):291-296.
22. Hahn T., Barth S., Weiss U., Mosgoeller W., Desoye G. Sustained hyperglycemia in vitro down-regulates the GLUT1 glucose transport system of cultured human term placental trophoblast: a mechanism to protect fetal development?. FASEB J. 1998, 12(12):1221-1231.
23. Hammond S.M., Sharpless N.E. HMGA2, microRNAs and stem cell aging. Cell 2008, 135(6):1013-1016.
24. Hardy T.M., Tollefsbol T.O. Epigenetic diet: impact on the epigenome and cancer. Epigenomics 2011, 3(4):503-518.
25. Hiyoshi Y., Kamohara H., Karashima R., Sato N., Imamura Y., Nagai Y., Yoshida N., Toyama E., Hayashi N., Watanabe M., Baba H. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin. Cancer Res. 2009, 15(6):1915-1922.
26. Hu S., Dong T.S., Dalal S.R., Wu F., Bissonnette M., Kwon J.H., Chang E.B. The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer. PLoS One 2011, 6(1):e16221.
27. Hursting S.D., Lashinger L.M., Colbert L.H., Rogers C.J., Wheatley K.W., Nunez N.P., Mahabir S., Barrett J.C., Forman M.R., Perkins S.N. Energy balance and carcinogenesis: underlying pathways and targets for intervention. Curr. Cancer Drug Targets 2007, 7(5):484-491.
28. Ivanovska I., Ball A.S., Diaz R.L., Magnus J.F., Kibukawa M., Schelter J.M., Kobayashi S.V., Lim L., Burchard J., Jackson A.L., Linsley P.S., Cleary M.A. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 2008, 28(7):2167-2174.
29. Jung H.J., Suh Y. MicroRNA in aging: from discovery to biology. Curr. Genomics 2012, 13(7):548-557.
30. Kala R., Peek G.W., Hardy T.M., Tollefsbol T.O. MicroRNAs: an emerging science in cancer epigenetics. J. Clin. Bioinforma 2013, 3(1):6.
31. Kasuga H., Fukuyama M., Kitazawa A., Kontani K., Katada T. The microRNA miR-235 couples blast-cell quiescence to the nutritional state. Nature 2013, 497(7450):503-506.
32. Kim Y.J., Hwang S.H., Cho H.H., Shin K.K., Bae Y.C., Jung J.S. MicroRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat diet-induced obesity alters microRNA 21 expression in white adipose tissues. J. Cell. Physiol. 2012, 227(1):183-193.
33. Kolfschoten I.G., Roggli E., Nesca V., Regazzi R. Role and therapeutic potential of microRNAs in diabetes. Diabetes Obes. Metab. 2009, 11(Suppl. 4):118-129.
34. Lee E.J., Gusev Y., Jiang J., Nuovo G.J., Lerner M.R., Frankel W.L., Morgan D.L., Postier R.G., Brackett D.J., Schmittgen T.D. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 2007, 120(5):1046-1054.
35. Li Y., Song Y.H., Li F., Yang T., Lu Y.W., Geng Y.J. MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem. Biophys. Res. Commun. 2009, 381(1):81-83.
36. Li Y., VandenBoom T.G., Kong D., Wang Z., Ali S., Philip P.A., Sarkar F.H. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009, 69(16):6704-6712.
37. Li H., Jia Z., Li A., Jenkins G., Yang X., Hu J., Guo W. Resveratrol repressed viability of U251 cells by miR-21 inhibiting of NF-kappaB pathway. Mol. Cell. Biochem. 2013, 382(1-2):137-143.
38. Lin Q., Gao Z., Alarcon R.M., Ye J., Yun Z. A role of miR-27 in the regulation of adipogenesis. FEBS J. 2009, 276(8):2348-2358.
39. Liu C., Yu J., Yu S., Lavker R.M., Cai L., Liu W., Yang K., He X., Chen S. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J. Hepatol. 2010, 53(1):98-107.
40. Lopez-Otin C., Blasco M.A., Partidge L., Serrano M., Kroemer G. The hallmarks of aging. Cell 2013, 153(6):1194-1217.
41. Marsit C.J., Eddy K., Kelsey K.T. MicroRNA responses to cellular stress. Cancer Res. 2006, 66(22):10843-10848.
42. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133(2):647-658.
43. Mogilyansky E., Rigoutsos I. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 2013, 20(12):1603-1614.
44. Nesca V., Guay C., Jacovetti C., Menoud V., Peyot M.L., Laybutt D.R., Prentki M., Regazzi R. Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 2013, 56(10):2203-2212.
45. Nteeba J., Ross J.W., Perfield Ii J.W., Keating A.F. High fat diet induced obesity alters ovarian phosphatidylinositol-3 kinase signaling gene expression. Reprod. Toxicol. 2013, 42:68-77.
46. Olivieri F., Rippo M.R., Procopio A.D., Fazioli F. Circulating inflamma-miRs in aging and age-related diseases. Front. Genet. 2013, 4:121.
47. Orum U., Lim M.K., Savage J.E., Jin L., Saleh A.D., Lisanti M.P., Simone N.L. Micro-RNA-203 regulates caveolin-1 in breast tissue during caloric restriction. Cell Cycle. 2012, 11(7):1291-1295.
48. Parra P., Serra F., Palou A. Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS One 2010, 5(9):e13005.
49. Pogribny I.P., Starlard-Davenport A., Tryndyak V.P., Han T., Ross S.A., Rusyn I., Beland F.A. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary non-alcoholic steatohepatitis in mice. Lab. Invest. 2010, 90(10):1437-1446.
50. Recchiuti A., Krishnamoorthy S., Fredman G., Chiang N., Serhan C.N. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB J. 2011, 25(2):544-560.
51. Roush S., Slack F.J. The let-7 family of microRNAs. Trends Cell Biol. 2008, 18(10):505-516.
52. Saini S., Arora S., Majid S., Shahryari V., Chen Y., Deng G., Yamamura S., Ueno K., Dahiya R. Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev. Res. (Phila) 2011, 4(10):1698-1709.
53. Saleh A.D., Simone B.A., Palazzo J., Savage J.E., Sano Y., Dan T., Jin L., Champ C.E., Zhao S., Lim M., Sotgia F., Camphausen K., Pestell R.G., Mitchell J.B., Lisanti M.P., Simone N.L. Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle 2013, 12(12):1955-1963.
54. Sene Lde B., Mesquita F.F., de Moraes L.N., Santos D.C., Carvalho R., Gontijo J.A., Boer P.A. Involvement of renal corpuscle microRNA expression on epithelial-to-mesenchymal transition in maternal low protein diet in adult programmed rats. PLoS One 2013, 8(8):e71310.
55. Shah M.S., Schwartz S.L., Zhao C., Davidson L.A., Zhou B., Lupton J.R., Ivanov I., Chapkin R.S. Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: effect of a chemo-protective diet. Physiol. Genomics 2011, 43(10):640-654.
56. Sheth S., Jajoo S., Kaur T., Mukherjea D., Sheehan K., Rybak L.P., Ramkumar V. Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. PLoS One 2012, 7(12):e51655.
57. Shyh-Chang N., Zhu H., Yvanka de Soysa T., Shinoda G., Seligson M.T., Tsanov K.M., Nguyen L., Asara J.M., Cantley L.C., Daley G.Q. Lin28 enhances tissue repair by reprogramming cellular metabolism. Cell 2013, 155(4):778-792.
58. Simone N.L., Soule B.P., Ly D., Saleh A.D., Savage J.E., Degraff W., Cook J., Harris C.C., Gius D., Mitchell J.B. Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One 2009, 4(7):e6377.
59. Sonkoly E., Wei T., Pavez Loriè E., Suzuki H., Kato M., Törmä H., Ståhle M., Pivarcsi A. Protein kinase C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes. J. Invest. Dermatol. 2010, 130(1):124-134.
60. Tanzer A., Stadler P.F. Molecular evolution of a microRNA cluster. J. Mol. Biol. 2004, 339(2):327-335.
61. Tili E., Michaille J.J. Resveratrol, microRNAs, inflammation, and cancer. J. Nucleic Acids 2011, 102431.
62. Tryndyak V.P., Ross S.A., Beland F.A., Pogribny I.P. Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol. Carcinog. 2009, 48(6):479-487.
63. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(7):2257-2261.
64. Volinia S., Galasso M., Costinean S., Tagliavini L., Gamberoni G., Drusco A., Marchesini J., Mascellani N., Sana M.E., Abu Jarour R., Desponts C., Teitell M., Baffa R., Aqeilan R., Iorio M.V., Taccioli C., Garzon R., Di Leva G., Fabbri M., Catozzi M., Previati M., Ambs S., Palumbo T., Garofalo M., Veronese A., Bottoni A., Gasparini P., Harris C.C., Visone R., Pekarsky Y., de la Chapelle A., Bloomston M., Dillhoff M., Rassenti L.Z., Kipps T.J., Huebner K., Pichiorri F., Lenze D., Cairo S., Buendia M.A., Pineau P., Dejean A., Zanesi N., Rossi S., Calin G.A., Liu C.G., Palatini J., Negrini M., Vecchione A., Rosenberg A., Croce C.M. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 2010, 20(5):589-599.
65. Vora M., Shah M., Osatfi S., Onken B., Xue J., Ni J.Z., Gu S., Driscoll M. Deletion of microRNA-80 activates dietary restriction to extend C. elegans healthspan and lifespan. PLoS Genet. 2013, 9(8):e1003737.
66. Wicki A., Hagmann J. Diet and cancer. Swiss Med. Wkly. 2011, 141:w13250.
67. Wolter F., Stein J. Resveratrol enhances the differentiation induced by butyrate in caco-2 colon cancer cells. J. Nutr. 2002, 132(7):2082-2086.
68. Xiong M., Jiang L., Zhou Y., Qiu W., Fang L., Tan R., Wen P., Yang J. The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am. J. Physiol. Renal Physiol. 2012, 302(3):F369-F379.
69. Yamamichi N., Shimomura R., Inada K., Sakurai K., Haraguchi T., Ozaki Y., Fujita S., Mizutani T., Furukawa C., Fujishiro M., Ichinose M., Shiogama K., Tsutsumi Y., Omata M., Iba H. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin. Cancer Res. 2009, 15(12):4009-4016.
70. Zacharewicz E., Lamon S., Russell A.P. MicroRNAs in skeletal muscle and their regulation with exercise, ageing, and disease. Front. Physiol. 2013, 4:266.
71. Zhu H., Shyh-Chang N., Segre A.V., Shinoda G., Shah S.P., Einhorn W.S., Takeuchi A., Engreitz J.M., Hagan J.P., Kharas M.G., Urbach A., Thornton J.E., Triboulet R., Gregory R.I., Altshuler D., Daley G.Q. The Lin28/let-7 axis regulates glucose metabolism. Cell 2011, 147(1):81-94.